Skip to main content

Clinical Trials: Some General Considerations

  • Conference paper
Thrombolytic Therapy in Acute Ischemic Stroke
  • 73 Accesses

Abstract

Trials might be compared to the famous little girl with a curl in the middle of her forehead. You recall that when she was good, she was very, very good, but when she was bad, she was horrid. There is no more useful vehicle in all of clinical medicine than an effective, well-designed, well-analyzed trial. There is also, however, an abundance of very bad trials that waste our resources and time and yield few answers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Caplan, L.R. (1991). Clinical Trials: Some General Considerations. In: Hacke, W., del Zoppo, G.J., Hirschberg, M. (eds) Thrombolytic Therapy in Acute Ischemic Stroke. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76439-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76439-4_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53680-2

  • Online ISBN: 978-3-642-76439-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics